Centaurus Financial’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $493K | Sell |
7,053
-250
| -3% | -$17.5K | 0.03% | 482 |
|
|
2025
Q1 | $537K | Buy |
7,303
+995
| +16% | +$73.2K | 0.03% | 435 |
|
|
2024
Q4 | $413K | Buy |
6,308
+2,271
| +56% | +$149K | 0.03% | 490 |
|
|
2024
Q3 | $315K | Buy |
4,037
+1,700
| +73% | +$133K | 0.02% | 523 |
|
|
2024
Q2 | $182K | Buy |
+2,337
| New | +$182K | 0.01% | 627 |
|
|
2023
Q2 | – | Sell |
-2,056
| Closed | -$143K | – | 753 |
|
|
2023
Q1 | $143K | Sell |
2,056
-6
| -0.3% | -$417 | 0.01% | 755 |
|
|
2022
Q4 | $140K | Sell |
2,062
-43
| -2% | -$2.92K | 0.01% | 696 |
|
|
2022
Q3 | $115K | Sell |
2,105
-971
| -32% | -$53K | 0.01% | 760 |
|
|
2022
Q2 | $203K | Sell |
3,076
-406
| -12% | -$26.8K | 0.02% | 605 |
|
|
2022
Q1 | $231K | Sell |
3,482
-3,020
| -46% | -$200K | 0.02% | 626 |
|
|
2021
Q4 | $379K | Sell |
6,502
-470
| -7% | -$27.4K | 0.03% | 514 |
|
|
2021
Q3 | $419K | Sell |
6,972
-363
| -5% | -$21.8K | 0.04% | 461 |
|
|
2021
Q2 | $439K | Sell |
7,335
-1,250
| -15% | -$74.8K | 0.04% | 462 |
|
|
2021
Q1 | $427K | Sell |
8,585
-7,861
| -48% | -$391K | 0.04% | 410 |
|
|
2020
Q4 | $822K | Buy |
16,446
+1,352
| +9% | +$67.6K | 0.09% | 265 |
|
|
2020
Q3 | $827K | Buy |
15,094
+10,782
| +250% | +$591K | 0.11% | 199 |
|
|
2020
Q2 | $228K | Buy |
+4,312
| New | +$228K | 0.03% | 395 |
|
|
2018
Q3 | – | Sell |
-7,921
| Closed | -$278K | – | 650 |
|
|
2018
Q2 | $278K | Buy |
+7,921
| New | +$278K | 0.04% | 435 |
|